TY - JOUR
T1 - Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM)
T2 - Cluster randomised controlled trial
AU - Blum, Manuel R.
AU - Sallevelt, Bastiaan T.G.M.
AU - Spinewine, Anne
AU - O'Mahony, Denis
AU - Moutzouri, Elisavet
AU - Feller, Martin
AU - Baumgartner, Christine
AU - Roumet, Marie
AU - Jungo, Katharina Tabea
AU - Schwab, Nathalie
AU - Bretagne, Lisa
AU - Beglinger, Shanthi
AU - Aubert, Carole E.
AU - Wilting, Ingeborg
AU - Thevelin, Stefanie
AU - Murphy, Kevin
AU - Huibers, Corlina J.A.
AU - Clara Drenth-Van Maanen, A.
AU - Boland, Benoit
AU - Crowley, Erin
AU - Eichenberger, Anne
AU - Meulendijk, Michiel
AU - Jennings, Emma
AU - Adam, Luise
AU - Roos, Marvin J.
AU - Gleeson, Laura
AU - Shen, Zhengru
AU - Marien, Sophie
AU - Meinders, Arend Jan
AU - Baretella, Oliver
AU - Netzer, Seraina
AU - De Montmollin, Maria
AU - Fournier, Anne
AU - Mouzon, Ariane
AU - O'Mahony, Cian
AU - Aujesky, Drahomir
AU - Mavridis, Dimitris
AU - Byrne, Stephen
AU - Jansen, Paul A.F.
AU - Schwenkglenks, Matthias
AU - Spruit, Marco
AU - Dalleur, Olivia
AU - Knol, Wilma
AU - Trelle, Sven
AU - Rodondi, Nicolas
N1 - Publisher Copyright:
©
PY - 2021/7/13
Y1 - 2021/7/13
N2 - Objective To examine the effect of optimising drug treatment on drug related hospital admissions in older adults with multimorbidity and polypharmacy admitted to hospital. Design Cluster randomised controlled trial. Setting 110 clusters of inpatient wards within university based hospitals in four European countries (Switzerland, Netherlands, Belgium, and Republic of Ireland) defined by attending hospital doctors. Participants 2008 older adults (≥70 years) with multimorbidity (≥3 chronic conditions) and polypharmacy (≥5 drugs used long term). Intervention Clinical staff clusters were randomised to usual care or a structured pharmacotherapy optimisation intervention performed at the individual level jointly by a doctor and a pharmacist, with the support of a clinical decision software system deploying the screening tool of older person's prescriptions and screening tool to alert to the right treatment (STOPP/START) criteria to identify potentially inappropriate prescribing. Main outcome measure Primary outcome was first drug related hospital admission within 12 months. Results 2008 older adults (median nine drugs) were randomised and enrolled in 54 intervention clusters (963 participants) and 56 control clusters (1045 participants) receiving usual care. In the intervention arm, 86.1% of participants (n=789) had inappropriate prescribing, with a mean of 2.75 (SD 2.24) STOPP/START recommendations for each participant. 62.2% (n=491) had ≥1 recommendation successfully implemented at two months, predominantly discontinuation of potentially inappropriate drugs. In the intervention group, 211 participants (21.9%) experienced a first drug related hospital admission compared with 234 (22.4%) in the control group. In the intention-to-treat analysis censored for death as competing event (n=375, 18.7%), the hazard ratio for first drug related hospital admission was 0.95 (95% confidence interval 0.77 to 1.17). In the per protocol analysis, the hazard ratio for a drug related hospital admission was 0.91 (0.69 to 1.19). The hazard ratio for first fall was 0.96 (0.79 to 1.15; 237 v 263 first falls) and for death was 0.90 (0.71 to 1.13; 172 v 203 deaths). Conclusions Inappropriate prescribing was common in older adults with multimorbidity and polypharmacy admitted to hospital and was reduced through an intervention to optimise pharmacotherapy, but without effect on drug related hospital admissions. Additional efforts are needed to identify pharmacotherapy optimisation interventions that reduce inappropriate prescribing and improve patient outcomes. Trial registration ClinicalTrials.gov NCT02986425.
AB - Objective To examine the effect of optimising drug treatment on drug related hospital admissions in older adults with multimorbidity and polypharmacy admitted to hospital. Design Cluster randomised controlled trial. Setting 110 clusters of inpatient wards within university based hospitals in four European countries (Switzerland, Netherlands, Belgium, and Republic of Ireland) defined by attending hospital doctors. Participants 2008 older adults (≥70 years) with multimorbidity (≥3 chronic conditions) and polypharmacy (≥5 drugs used long term). Intervention Clinical staff clusters were randomised to usual care or a structured pharmacotherapy optimisation intervention performed at the individual level jointly by a doctor and a pharmacist, with the support of a clinical decision software system deploying the screening tool of older person's prescriptions and screening tool to alert to the right treatment (STOPP/START) criteria to identify potentially inappropriate prescribing. Main outcome measure Primary outcome was first drug related hospital admission within 12 months. Results 2008 older adults (median nine drugs) were randomised and enrolled in 54 intervention clusters (963 participants) and 56 control clusters (1045 participants) receiving usual care. In the intervention arm, 86.1% of participants (n=789) had inappropriate prescribing, with a mean of 2.75 (SD 2.24) STOPP/START recommendations for each participant. 62.2% (n=491) had ≥1 recommendation successfully implemented at two months, predominantly discontinuation of potentially inappropriate drugs. In the intervention group, 211 participants (21.9%) experienced a first drug related hospital admission compared with 234 (22.4%) in the control group. In the intention-to-treat analysis censored for death as competing event (n=375, 18.7%), the hazard ratio for first drug related hospital admission was 0.95 (95% confidence interval 0.77 to 1.17). In the per protocol analysis, the hazard ratio for a drug related hospital admission was 0.91 (0.69 to 1.19). The hazard ratio for first fall was 0.96 (0.79 to 1.15; 237 v 263 first falls) and for death was 0.90 (0.71 to 1.13; 172 v 203 deaths). Conclusions Inappropriate prescribing was common in older adults with multimorbidity and polypharmacy admitted to hospital and was reduced through an intervention to optimise pharmacotherapy, but without effect on drug related hospital admissions. Additional efforts are needed to identify pharmacotherapy optimisation interventions that reduce inappropriate prescribing and improve patient outcomes. Trial registration ClinicalTrials.gov NCT02986425.
UR - https://www.scopus.com/pages/publications/85110544273
U2 - 10.1136/bmj.n1585
DO - 10.1136/bmj.n1585
M3 - Article
C2 - 34257088
AN - SCOPUS:85110544273
SN - 0959-8146
VL - 374
JO - BMJ
JF - BMJ
M1 - n1585
ER -